AM-Pharma is a biopharmaceutical company, engaged in the development of proprietary recombinant human Alkaline Phosphatase (recAP). The Company’s lead programs with this therapeutic enzyme are in Acute Kidney Injury, Inflammatory Bowel Disease and Hypophosphatasia.
